The Asia Pacific Federation for Clinical Biochemistry and Laboratory Medicine (APFCB) had its humble beginnings in the late 1970s. Today in 2018, after forty years of growth and development, the APFCB is the largest of the six regional federations of clinical chemistry and laboratory medicine. The APFCB is a massive regional federation with 18 full Ordinary Members, 6 Affiliate Members and 18 Corporate Members, and we comprise:
The following Full Members:
The following Affiliate Members:
In addition, the APFCB has close partnership and collaboration with eighteen in-vitro diagnostic companies, comprising global multinational, regional and local companies. Our corporate partners support the APFCB in many of its activities.
Apart from the size, a feature of the APFCB is the diverse range of laboratory practices, within the federation. This puts us in a unique position for drawing on the expertise of the more developed societies to assist the less developed. Over the years, the APFCB travelling lecturer program has been enabling information and technology transfer within the region.
The APFCB has a good history of collaboration with other international federations. We have a long standing partnership and good support from the IFCC. In addition, the APFCB has on-going MoUs with the World Association of Societies of Pathology and Laboratory Medicine (WASPaLM) and the American Association for Clinical Chemistry (AACC).
At our last APFCB council meeting in Taipei, Taiwan, we resolved to have the following calendar for future APFCB Congresses:
15th APFCB Congress in Jaipur, India, 17-20 November 2019
16th APFCB Congress in Sydney, NSW, Australia, 15-18 October 2022.
I am pleased to announce that it was also resolved that beyond the year 2022, the APFCB Congresses will be subsequently held every two years, instead of the current three-yearly cycles. This will mean that the 17th APFCB Congress will be held in 2024, at a destination, which will be decided at the next council meeting.
In 2018, the APFCB EB and Working Committees have put together an ambitious plan for a variety of activities. Details of our ongoing scientific and educational activities are on the APFCB website and our communications committee will feature a rich array of articles, reports and interesting information. I strongly encourage you to visit all the sections of our website at www.apfcb.org.
One activity in 2018 which I would like to highlight is the AACC- APFCB Global Laboratory Quality Workshop series “Adding Value to Patient Care Using Quality Control”. This will feature a series of workshops in Nepal, Sri Lanka and the Philippines. The team is already putting together an exciting program for the workshops.
In this brief introduction to the APFCB, I would like to end by indicating that the APFCB Executive Board is actively looking for participation from our younger colleagues and laboratory professionals. We do need renewal and succession as we prepare to support our healthcare partners to manage their patients. Do participate in the activities of the APFCB and do step forward to contribute where possible.
To everyone else outside the Asia Pacific, I do welcome you to engage the federation, collaborate with us, participate in our activities and become part of the family.
Dr. Sunil Sethi
Head Clinical Chemistry
Department of Laboratory Medicine
National University Hospital
5 Lower Kent Ridge Road
Tel: +65-6772 4347
Fax: +65 6779 5555